Company AnnouncementTransaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction anticipated to be accretive to Genmab’s EBITDA by end ...

KUALA LUMPUR, MY / ACCESS Newswire / December 12, 2025 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") a provider of health and wellness products and sustainable energy solutions, ...

Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...

Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...

- Three Phase 2 data readouts from lead programs, EVO756 and EVO301, expected in 2026 across atopic dermatitis (AD) and ...

Funding will further scale the company’s multimodal ML platform for patient selectionSAN FRANCISCO--(BUSINESS ...

Concise regulatory statusPivotal trialOveporextonTakedaNarcolepsy (orexin‑2 agonist)US, EU, JPPhase III completed; filings ...

Accenture (NYSE: ACN) has invested in Ryght AI, a platform provider that modernizes how clinical research is designed and ...

Today, ACRO announced that its Board of Directors elected Cassandra “Sandy” Kennedy, Chief Quality, Regulatory Affairs, and ...

Major regulatory overhaul in the EUThe European Union’s lawmakers have agreed a provisional pharma package to modernise ...

Pharmaffiliates is proud to announce a remarkable achievement at the SME-Empowering India Awards 2025, where the organization ...